TriSalus Life Sciences Research and Development Expenses 2021-2024 | TLSI

TriSalus Life Sciences research and development expenses from 2021 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

TriSalus Life Sciences Research and Development Expenses 2021-2024 | TLSI

TriSalus Life Sciences research and development expenses from 2021 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$204.2B
Stryker (SYK)$146.7B
Boston Scientific (BSX)$132.6B
EssilorLuxottica (ESLOY)$112.1B
Medtronic (MDT)$110.6B
Haleon (HLN)$43.7B
Lonza Group Ag (LZAGY)$42.2B
GE HealthCare Technologies (GEHC)$37.7B
ResMed (RMD)$35.8B
Terumo (TRUMY)$29.7B
Koninklijke Philips (PHG)$24.8B
Zimmer Biomet Holdings (ZBH)$21.9B
Insulet (PODD)$18.4B
Baxter (BAX)$17B
Smith & Nephew SNATS (SNN)$11.1B
BellRing Brands (BRBR)$10.2B
Bio-Rad Laboratories (BIO)$9.3B
Demant (WILYY)$8.3B
Lantheus Holdings (LNTH)$6.3B
TG Therapeutics (TGTX)$5.5B
Haemonetics (HAE)$4.3B
Prestige Consumer Healthcare (PBH)$4.2B
ICU Medical (ICUI)$4.1B
Perrigo (PRGO)$3.8B
Envista Holdings (NVST)$3.7B
Neogen (NEOG)$3.2B
Agios Pharmaceuticals (AGIO)$3.2B
Shandong Weigao Medical Polymer (SHWGF)$3B
GN Store Nord (GNNDY)$2.8B
QuidelOrtho (QDEL)$2.7B